Indication
Aortic Valve Disease
6 clinical trials
13 products
1 drug
Clinical trial
A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on ApixabanStatus: Terminated, Estimated PCD: 2022-12-12
Product
ApixabanProduct
WarfarinClinical trial
Dexamethasone, Olanzapine, Flow-targeted Versus Pressure-targeted Hemodynamic Management, and Low Tidal Volume Ventilation in Patients Undergoing On-pump Cardiac Surgery - a Multifactorial Design Randomized TrialStatus: Recruiting, Estimated PCD: 2027-12-01
Product
DexamethasoneProduct
Isotonic sodium chlorideProduct
OlanzapineProduct
PlaceboClinical trial
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation: a Prospective, Multicenter, Randomized StudyStatus: Recruiting, Estimated PCD: 2025-05-30
Product
Medical therapyClinical trial
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)Status: Completed, Estimated PCD: 2024-03-21
Clinical trial
Efficacy of a Glucagon-like-peptide-1 Agonist and Restrictive vs. Liberal Oxygen Supply in Patients Undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement - a 2-by-2 Factorial Designed, Randomized Clinical StudyStatus: Active (not recruiting), Estimated PCD: 2024-01-01
Product
ByettaProduct
ConoxiaProduct
Human AlbuminClinical trial
Does Colchicine Reduce Progression of Aortic Valve Stenosis?Status: Recruiting, Estimated PCD: 2025-12-22
Product
ColchicineDrug
Varlilumab